Prokinetic agent (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Prokinetic agent" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

10doi.org

2^nd place

1worldcat.org

5^th place

1web.archive.org

1^st place

1acidrefluxsymptomse.com

low place

1physiology.org

5,293^rd place

7,651^st place

1physoc.org

low place

1semanticscholar.org

11^th place

8^th place

acidrefluxsymptomse.com

"Acid Reflux Symptoms". Archived from the original on 2011-06-15. Retrieved 2011-06-23.

doi.org

Vincenzi M, Kremić A, Jouve A, Lattanzi R, Miele R, Benharouga M, Alfaidy N, Migrenne-Li S, Kanthasamy AG, Porcionatto M, Ferrara N, Tetko IV, Désaubry L, Nebigil CG (November 2023). Touyz R (ed.). "Therapeutic Potential of Targeting Prokineticin Receptors in Diseases". Pharmacological Reviews. 75 (6): 1167–1199. doi:10.1124/pharmrev.122.000801. ISSN 0031-6997. PMC 10595023. PMID 37684054.
Dickson, EJ.; Heredia, DJ.; Smith, TK. (Jul 2010). "Critical role of 5-HT1A, 5-HT3, and 5-HT7 receptor subtypes in the initiation, generation, and propagation of the murine colonic migrating motor complex". Am J Physiol Gastrointest Liver Physiol. 299 (1): G144–57. doi:10.1152/ajpgi.00496.2009. PMC 2904117. PMID 20413719.
Gershon, MD; Tack, J (2007). "The serotonin signaling system: from basic understanding to drug development for functional GI disorders". Gastroenterology. 132 (1): 397–414. doi:10.1053/j.gastro.2006.11.002. PMID 17241888.
Gorard DA, Libby GW, Farthing MJ (April 1994). "5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake". Gut. 35 (4): 496–500. doi:10.1136/gut.35.4.496. PMC 1374798. PMID 8174987.
Takanashi, H.; Cynshi, O. (Jun 2009). "Motilides: a long and winding road: lessons from mitemcinal (GM-611) on diabetic gastroparesis". Regul Pept. 155 (1–3): 18–23. doi:10.1016/j.regpep.2009.03.011. PMID 19345243.
Berthet, S.; Charpiat, B.; Mabrut, JY. (Apr 2010). "Erythromycin as a prokinetic agent: risk factors". Journal of Visceral Surgery. 147 (2): e13–8. doi:10.1016/j.jviscsurg.2010.06.001. PMID 20655290.
Lesniewska, V.; Rowland, I.; Laerke, HN.; Grant, G.; Naughton, PJ. (Jan 2006). "Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo". Exp Physiol. 91 (1): 229–37. doi:10.1113/expphysiol.2005.031708. PMID 16263800.
Husebye, E.; Hellström, PM.; Sundler, F.; Chen, J.; Midtvedt, T. (Mar 2001). "Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats". Am J Physiol Gastrointest Liver Physiol. 280 (3): G368–80. doi:10.1152/ajpgi.2001.280.3.G368. PMID 11171619.
Wu, RY.; Pasyk, M.; Wang, B.; Forsythe, P.; Bienenstock, J.; Mao, YK.; Sharma, P.; Stanisz, AM.; Kunze, WA. (Mar 2013). "Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains". Neurogastroenterol Motil. 25 (3): e205–14. doi:10.1111/nmo.12072. PMID 23316914.
Mozaffari, S.; Nikfar, S.; Abdollahi, M. (Apr 2013). "Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome". Expert Opin Drug Metab Toxicol. 9 (4): 403–21. doi:10.1517/17425255.2013.759558. PMID 23330973. S2CID 37740247.

nih.gov

pubmed.ncbi.nlm.nih.gov

Vincenzi M, Kremić A, Jouve A, Lattanzi R, Miele R, Benharouga M, Alfaidy N, Migrenne-Li S, Kanthasamy AG, Porcionatto M, Ferrara N, Tetko IV, Désaubry L, Nebigil CG (November 2023). Touyz R (ed.). "Therapeutic Potential of Targeting Prokineticin Receptors in Diseases". Pharmacological Reviews. 75 (6): 1167–1199. doi:10.1124/pharmrev.122.000801. ISSN 0031-6997. PMC 10595023. PMID 37684054.
Dickson, EJ.; Heredia, DJ.; Smith, TK. (Jul 2010). "Critical role of 5-HT1A, 5-HT3, and 5-HT7 receptor subtypes in the initiation, generation, and propagation of the murine colonic migrating motor complex". Am J Physiol Gastrointest Liver Physiol. 299 (1): G144–57. doi:10.1152/ajpgi.00496.2009. PMC 2904117. PMID 20413719.
Gershon, MD; Tack, J (2007). "The serotonin signaling system: from basic understanding to drug development for functional GI disorders". Gastroenterology. 132 (1): 397–414. doi:10.1053/j.gastro.2006.11.002. PMID 17241888.
Gorard DA, Libby GW, Farthing MJ (April 1994). "5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake". Gut. 35 (4): 496–500. doi:10.1136/gut.35.4.496. PMC 1374798. PMID 8174987.
Takanashi, H.; Cynshi, O. (Jun 2009). "Motilides: a long and winding road: lessons from mitemcinal (GM-611) on diabetic gastroparesis". Regul Pept. 155 (1–3): 18–23. doi:10.1016/j.regpep.2009.03.011. PMID 19345243.
Berthet, S.; Charpiat, B.; Mabrut, JY. (Apr 2010). "Erythromycin as a prokinetic agent: risk factors". Journal of Visceral Surgery. 147 (2): e13–8. doi:10.1016/j.jviscsurg.2010.06.001. PMID 20655290.
Depoortere, I. (2001). "Motilin and motilin receptors: characterization and functional significance". Verh K Acad Geneeskd Belg. 63 (6): 511–29. PMID 11813507.
Lesniewska, V.; Rowland, I.; Laerke, HN.; Grant, G.; Naughton, PJ. (Jan 2006). "Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo". Exp Physiol. 91 (1): 229–37. doi:10.1113/expphysiol.2005.031708. PMID 16263800.
Husebye, E.; Hellström, PM.; Sundler, F.; Chen, J.; Midtvedt, T. (Mar 2001). "Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats". Am J Physiol Gastrointest Liver Physiol. 280 (3): G368–80. doi:10.1152/ajpgi.2001.280.3.G368. PMID 11171619.
Wu, RY.; Pasyk, M.; Wang, B.; Forsythe, P.; Bienenstock, J.; Mao, YK.; Sharma, P.; Stanisz, AM.; Kunze, WA. (Mar 2013). "Spatiotemporal maps reveal regional differences in the effects on gut motility for Lactobacillus reuteri and rhamnosus strains". Neurogastroenterol Motil. 25 (3): e205–14. doi:10.1111/nmo.12072. PMID 23316914.
Mozaffari, S.; Nikfar, S.; Abdollahi, M. (Apr 2013). "Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome". Expert Opin Drug Metab Toxicol. 9 (4): 403–21. doi:10.1517/17425255.2013.759558. PMID 23330973. S2CID 37740247.

ncbi.nlm.nih.gov

Vincenzi M, Kremić A, Jouve A, Lattanzi R, Miele R, Benharouga M, Alfaidy N, Migrenne-Li S, Kanthasamy AG, Porcionatto M, Ferrara N, Tetko IV, Désaubry L, Nebigil CG (November 2023). Touyz R (ed.). "Therapeutic Potential of Targeting Prokineticin Receptors in Diseases". Pharmacological Reviews. 75 (6): 1167–1199. doi:10.1124/pharmrev.122.000801. ISSN 0031-6997. PMC 10595023. PMID 37684054.
Dickson, EJ.; Heredia, DJ.; Smith, TK. (Jul 2010). "Critical role of 5-HT1A, 5-HT3, and 5-HT7 receptor subtypes in the initiation, generation, and propagation of the murine colonic migrating motor complex". Am J Physiol Gastrointest Liver Physiol. 299 (1): G144–57. doi:10.1152/ajpgi.00496.2009. PMC 2904117. PMID 20413719.
Gorard DA, Libby GW, Farthing MJ (April 1994). "5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake". Gut. 35 (4): 496–500. doi:10.1136/gut.35.4.496. PMC 1374798. PMID 8174987.

physiology.org

ajpgi.physiology.org

Dickson, EJ.; Heredia, DJ.; Smith, TK. (Jul 2010). "Critical role of 5-HT1A, 5-HT3, and 5-HT7 receptor subtypes in the initiation, generation, and propagation of the murine colonic migrating motor complex". Am J Physiol Gastrointest Liver Physiol. 299 (1): G144–57. doi:10.1152/ajpgi.00496.2009. PMC 2904117. PMID 20413719.

physoc.org

ep.physoc.org

Lesniewska, V.; Rowland, I.; Laerke, HN.; Grant, G.; Naughton, PJ. (Jan 2006). "Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo". Exp Physiol. 91 (1): 229–37. doi:10.1113/expphysiol.2005.031708. PMID 16263800.

semanticscholar.org

api.semanticscholar.org

Mozaffari, S.; Nikfar, S.; Abdollahi, M. (Apr 2013). "Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome". Expert Opin Drug Metab Toxicol. 9 (4): 403–21. doi:10.1517/17425255.2013.759558. PMID 23330973. S2CID 37740247.

web.archive.org

"Acid Reflux Symptoms". Archived from the original on 2011-06-15. Retrieved 2011-06-23.

worldcat.org

search.worldcat.org

Vincenzi M, Kremić A, Jouve A, Lattanzi R, Miele R, Benharouga M, Alfaidy N, Migrenne-Li S, Kanthasamy AG, Porcionatto M, Ferrara N, Tetko IV, Désaubry L, Nebigil CG (November 2023). Touyz R (ed.). "Therapeutic Potential of Targeting Prokineticin Receptors in Diseases". Pharmacological Reviews. 75 (6): 1167–1199. doi:10.1124/pharmrev.122.000801. ISSN 0031-6997. PMC 10595023. PMID 37684054.